# RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI)

> **NCT03643861** · NA · RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 40 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** 5 Fraction Stereotactic Body Radiation Therapy

## Key facts

- **NCT ID:** NCT03643861
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-08-20
- **Primary completion:** 2027-12
- **Final completion:** 2028-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03643861

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03643861, "RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03643861. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*